Agency Information Collection Activities: Proposed Collection; Comments Requested: Reports of Dispensing of Controlled Substances by Online Pharmacies (DEA Form 332), 42329 [E9-20184]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
burden of 80 hours. It is estimated that
250 persons complete DEA Form 224c
electronically, at 15 minutes per form,
for an annual burden of 62.5 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that this
collection will create a burden of 56,354
annual burden hours.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: August 18, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E9–20183 Filed 8–20–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0050]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested: Reports of
Dispensing of Controlled Substances
by Online Pharmacies (DEA Form 332)
30-day notice of information
collection under review.
srobinson on DSKHWCL6B1PROD with NOTICES
ACTION:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 74, Number 113, page
28275, on June 15, 2009, allowing for a
60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until September 21, 2009.
This process is conducted in accordance
with 5 CFR 1320.10. Written comments
and/or suggestions regarding the items
contained in this notice, especially the
estimated public burden and associated
response time, should be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503.
Additionally, comments may be
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
submitted to OMB via facsimile to (202)
395–5806.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0050
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Reports of Dispensing of Controlled
Substances by Online Pharmacies (DEA
Form 332).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection:
Form Number: DEA Form 332; Office
of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Not-for-Profit Institutions;
State, Local or Tribal Government.
Abstract: The Controlled Substances
Act (21 U.S.C. 827(d)(2)) requires online
pharmacies to report to DEA the total
quantity of controlled substances that
the pharmacy has dispensed during
each calendar month by any means,
regardless of whether the controlled
substances are dispensed by means of
the Internet. Reports are required to be
filed by every pharmacy that, at any
time during a calendar month, holds a
modification of registration authorizing
it to operate as an online pharmacy,
regardless of whether the online
pharmacy dispenses any controlled
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
42329
substances by means of the Internet
during the month. Such reporting is
mandated by the Ryan Haight Act and
permits DEA to monitor the dispensing
of controlled substances by online
pharmacies.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 250 persons
complete DEA Form 332 electronically,
at 15 minutes per form, for an annual
burden of 750 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that this
collection will create a burden of 750
annual burden hours.
If additional information is required,
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: August 18, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E9–20184 Filed 8–21–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—American Society of
Mechanical Engineers
Notice is hereby given that, on July
20, 2009, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), American Society of
Mechanical Engineers (‘‘ASME’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, since May 7, 2009, ASME
has partitioned its existing standards
writing committee on Boilers and
Pressure Vessels into ten separate
standards writing committees, each with
its own individual charter; published
two new standards; and initiated three
new standards activities within the
general nature and scope of ASME’s
standards development activities, as
E:\FR\FM\21AUN1.SGM
21AUN1
]]>Agencies
[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Page 42329]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20184]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0050]
Agency Information Collection Activities: Proposed Collection;
Comments Requested: Reports of Dispensing of Controlled Substances by
Online Pharmacies (DEA Form 332)
ACTION: 30-day notice of information collection under review.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA), will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register Volume 74, Number 113,
page 28275, on June 15, 2009, allowing for a 60-day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until September 21, 2009. This process is conducted
in accordance with 5 CFR 1320.10. Written comments and/or suggestions
regarding the items contained in this notice, especially the estimated
public burden and associated response time, should be directed to the
Office of Management and Budget, Office of Information and Regulatory
Affairs, Attention Department of Justice Desk Officer, Washington, DC
20503. Additionally, comments may be submitted to OMB via facsimile to
(202) 395-5806.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of Information Collection 1117-0050
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Reports of Dispensing of
Controlled Substances by Online Pharmacies (DEA Form 332).
(3) Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection:
Form Number: DEA Form 332; Office of Diversion Control, Drug
Enforcement Administration, Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: Not-for-Profit Institutions; State, Local or Tribal
Government.
Abstract: The Controlled Substances Act (21 U.S.C. 827(d)(2))
requires online pharmacies to report to DEA the total quantity of
controlled substances that the pharmacy has dispensed during each
calendar month by any means, regardless of whether the controlled
substances are dispensed by means of the Internet. Reports are required
to be filed by every pharmacy that, at any time during a calendar
month, holds a modification of registration authorizing it to operate
as an online pharmacy, regardless of whether the online pharmacy
dispenses any controlled substances by means of the Internet during the
month. Such reporting is mandated by the Ryan Haight Act and permits
DEA to monitor the dispensing of controlled substances by online
pharmacies.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: It is estimated
that 250 persons complete DEA Form 332 electronically, at 15 minutes
per form, for an annual burden of 750 hours.
(6) An estimate of the total public burden (in hours) associated
with the collection: It is estimated that this collection will create a
burden of 750 annual burden hours.
If additional information is required, contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: August 18, 2009.
Lynn Bryant,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. E9-20184 Filed 8-21-09; 8:45 am]
BILLING CODE 4410-09-P
